Roger Stupp Selected Research

Glioblastoma (Glioblastoma Multiforme)

3/2022	Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.
1/2022	Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma.
1/2022	Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma.
1/2022	The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns.
12/2021	ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.
1/2021	De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma.
1/2021	PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells.
11/2020	Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes.
1/2020	Determining the Optimal Adjuvant Therapy for Improving Survival in Elderly Patients with Glioblastoma: A Systematic Review and Network Meta-analysis.
1/2020	Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roger Stupp Research Topics

Disease

93	Glioblastoma (Glioblastoma Multiforme) 03/2022 - 03/2002
89	Neoplasms (Cancer) 12/2022 - 01/2003
53	Glioma (Gliomas) 01/2022 - 10/2003
14	Brain Neoplasms (Brain Tumor) 01/2021 - 06/2004
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 05/2003
9	Astrocytoma (Pilocytic Astrocytoma) 11/2016 - 03/2002
6	Thrombocytopenia (Thrombopenia) 01/2022 - 03/2002
6	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2006
6	Neutropenia 01/2022 - 03/2002
6	Epilepsy (Aura) 10/2021 - 12/2010
6	Neoplasm Metastasis (Metastasis) 07/2019 - 02/2004
5	Seizures (Absence Seizure) 01/2021 - 02/2009
5	Melanoma (Melanoma, Malignant) 01/2020 - 02/2006
5	Oligodendroglioma 11/2016 - 02/2006
4	Lymphopenia (Lymphocytopenia) 01/2022 - 06/2006
4	Disease Progression 09/2014 - 02/2004
3	Fatigue 05/2020 - 11/2016
3	Pain (Aches) 01/2018 - 01/2003
3	Multiple Myeloma 01/2018 - 01/2015
3	Body Weight (Weight, Body) 01/2018 - 01/2015
3	Infections 11/2016 - 09/2012
3	Hypoxia (Hypoxemia) 10/2016 - 01/2009
3	Necrosis 01/2013 - 10/2003
3	Colorectal Neoplasms (Colorectal Cancer) 06/2008 - 04/2002
3	Carcinoma (Carcinomatosis) 08/2007 - 08/2003
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2009
2	Carcinogenesis 01/2020 - 01/2003
2	Nausea 01/2020 - 06/2006
2	Malignant Mesothelioma 01/2018 - 09/2008
2	Lymphoma (Lymphomas) 01/2018 - 12/2010
2	Pneumonia (Pneumonitis) 01/2018 - 06/2006
2	Headache (Headaches) 10/2017 - 06/2006
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2010 - 06/2004

Drug/Important Bio-Agent (IBA)

64	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 03/2002
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2003
14	MethyltransferasesIBA 01/2019 - 03/2004
14	CilengitideIBA 05/2018 - 09/2007
13	IntegrinsIBA 07/2019 - 09/2007
13	Alkylating AgentsIBA 10/2012 - 03/2002
12	Pharmaceutical PreparationsIBA 01/2022 - 04/2005
10	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 08/2006
9	Anticonvulsants (Antiepileptic Drugs)IBA 10/2021 - 02/2009
9	Bevacizumab (Avastin)FDA Link 11/2017 - 09/2007
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2006
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 10/2003
6	Lomustine (CCNU)FDA Link 01/2020 - 09/2007
6	Biological ProductsIBA 01/2017 - 01/2007
5	EnzymesIBA 01/2019 - 01/2007
5	O-(6)-methylguanineIBA 01/2019 - 09/2008
5	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 05/2003
5	O(6)-Methylguanine-DNA MethyltransferaseIBA 10/2012 - 08/2006
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 06/2006
4	Imatinib Mesylate (Gleevec)FDA Link 03/2012 - 02/2006
4	Angiogenesis InhibitorsIBA 12/2010 - 12/2003
3	Antimitotic AgentsIBA 01/2022 - 12/2015
3	ChromatinIBA 01/2021 - 01/2011
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 09/2007
3	Procarbazine (Matulane)FDA Link 01/2020 - 09/2007
3	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 09/2007
3	Vinorelbine (Navelbine)FDA LinkGeneric 01/2018 - 01/2015
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018 - 09/2012
3	Filgrastim (Neupogen)FDA Link 01/2018 - 01/2015
3	Rituximab (Mabthera)FDA Link 01/2014 - 06/2004
3	ErbB Receptors (EGF Receptor)IBA 06/2008 - 02/2006
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2020
2	Albumin-Bound Paclitaxel FDA Link 12/2021 - 01/2020
2	CateninsIBA 01/2020 - 12/2011
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2019 - 11/2017
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2018
2	Gemcitabine FDA Link 11/2018 - 01/2009
2	Immune Checkpoint InhibitorsIBA 01/2018 - 01/2018
2	IpilimumabIBA 01/2018 - 12/2012
2	AntigensIBA 01/2018 - 12/2012
2	Antineoplastic Agents (Antineoplastics)IBA 10/2016 - 08/2009
2	temsirolimus FDA Link 10/2016 - 09/2007
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2016 - 01/2016
2	SteroidsIBA 03/2016 - 01/2016
2	Valproic Acid (Depakote)FDA LinkGeneric 03/2016 - 12/2008
2	Levetiracetam (Keppra)FDA LinkGeneric 03/2016 - 04/2014
2	Prostaglandins BIBA 04/2014 - 02/2009
2	Pregabalin (Lyrica)FDA Link 04/2014 - 02/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013 - 01/2013
2	EMD 521873IBA 01/2013 - 01/2013
2	Interleukin-2 (IL2)IBA 01/2013 - 01/2013
2	A-Form DNA (A-DNA)IBA 01/2013 - 01/2007
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 03/2012 - 02/2006
2	Gefitinib (Iressa)FDA Link 02/2012 - 02/2006
2	GuanineIBA 01/2011 - 09/2007
2	Peptides (Polypeptides)IBA 01/2011 - 08/2008
2	vatalanib (PTK787)IBA 01/2010 - 09/2007

Therapy/Procedure

62	Radiotherapy 01/2021 - 01/2003
51	Therapeutics 12/2022 - 03/2002
49	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
22	Chemoradiotherapy 01/2022 - 03/2002
8	Immunotherapy 03/2022 - 01/2016
3	Neoadjuvant Therapy 09/2015 - 05/2003
3	Precision Medicine 01/2012 - 01/2010
2	Aftercare (After-Treatment) 01/2021 - 01/2020
2	Adjuvant Radiotherapy 01/2019 - 03/2005
2	Oral Administration 11/2016 - 04/2014